Prelude Therapeutics
Price & Volume
Stats
See more52W Range | $0.79-$6.80 |
Market Cap | $76.4M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $3M |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.77 |
News
See moreYahoo Finance • last year
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Prelude Therapeutics Incorporated (NASDAQ: PRLD) and Encourages Investors to Contact the Firm
Yahoo Finance • last year
Prelude Therapeutics Insiders Are Down US$149k But Regain Some Losses
Yahoo Finance • last year
Investor Alert: Abbott Cooper PLLC Investigates Prelude Therapeutics Incorporated; Urges Prelude Stockholders to Contact Abbott Cooper Regarding Their Legal Rights
Yahoo Finance • last year
Q3 2023 Abcellera Biologics Inc Earnings Call
About
CEO | Dr. Krishna Vaddi D.V.M., Ph.D. |
CFO | Mr. Bryant David Lim J.D. |
Address | 175 Innovation Boulevard, Wilmington, DE, United States, 19805 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 128 |
